(Total Views: 306)
Posted On: 11/12/2021 8:20:49 AM
Post# of 64

$CGEN News Article - Compugen Presents Preliminary Results from Phase 1/2 Dose Escalation Study of COM701 with Opdivo and BMS-986207 (Anti-TIGIT Antibody) at SITC 2021 https://marketwirenews.com/news-releases/comp...28256.html


My Twitter: WhyteStocks